BackInstadose Pharma Overview

Instadose Pharma Total Current Liabilities

Instadose Pharma's total current liabilities is $10M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$10.20M
↑ 64058.85% YoYΔ $10.18M vs prior year quarter

Peer trimmed avg / median

Loading

Instadose Pharma Total Current Liabilities History

Loading

Instadose Pharma vs. peers: Total Current Liabilities Comparison

Loading

Instadose Pharma Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Instadose Pharma (INSD) FAQ

As of the most recent data (February 2022), INSD shows a total current liabilities of $10M. That compares with $16K in the prior-year period — up 64058.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INSD's total current liabilities is now $10M (was $16K) — a 64058.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Instadose Pharma is outperforming or lagging.

Tracking INSD's total current liabilities over time shows whether Instadose Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $16K in the prior-year period — up 64058.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Instadose Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $10M) with ownership activity and broader fundamentals.